[
  {
    "ts": null,
    "headline": "Johnson & Johnson Announces New Icotrokinra (JNJ-2113) Data from its Comprehensive Phase 3 Clinical Program",
    "summary": "Johnson & Johnson announced new icotrokinra data from its comprehensive Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis seeking to demonstrate the...",
    "url": "https://finnhub.io/api/news?id=2da198b2a3586fc4f64993da1d20fdf3f7f174e126dcc0ac4d976c6026e4eb8c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741424400,
      "headline": "Johnson & Johnson Announces New Icotrokinra (JNJ-2113) Data from its Comprehensive Phase 3 Clinical Program",
      "id": 133107876,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson announced new icotrokinra data from its comprehensive Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis seeking to demonstrate the...",
      "url": "https://finnhub.io/api/news?id=2da198b2a3586fc4f64993da1d20fdf3f7f174e126dcc0ac4d976c6026e4eb8c"
    }
  }
]